Finally, we have recently shown that different genetic variants influence type 2 diabetes risk at distinct stages of the normoglycemia to IFG to type 2 diabetes progression, with MTNR1B and GCK exerting their effects preferentially in the normoglycemia to IFG transition [13]. This evidence concerns the gene GCK and type 2 diabetes mellitus.